SYCP2 and ovarian cancer: Notably, in both Cancer Genomic Atlas (TCGA) and CCLE databases, the meiotic gene SYCP2 is commonly upregulated in breast, cervical, and ovarian cancers and also detected in other cancer types, including lung, head-and-neck, and bladder cancers (Fig. 1B).